Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kpb

Michelle J. Bleile, Asha Rijhsinghani, Denis M Dwyre, Thomas J. Raife

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: The incidence of hemolytic disease of the fetus and newborn (HDFN) has decreased since the introduction of Rh immunoglobulin prophylaxis in Rh(D)-negative pregnant women. Thus, the relative incidence of rare alloantibody-related HDFN has increased. The lack of available maternally matched red blood cells for transfusion in these cases may create management difficulties. Case: We report a case of anti-Kpb HDFN. Severe fetal anemia required intrauterine transfusion. Difficulty in obtaining Kpb-negative blood necessitated using the mother's donated RBCs. Conclusion: Severe HDFN with rare antibodies can be managed successfully using maternal blood.

Original languageEnglish (US)
Pages (from-to)281-283
Number of pages3
JournalTransfusion and Apheresis Science
Volume43
Issue number3
DOIs
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

Fetal Erythroblastosis
Fetus
Mothers
Intrauterine Blood Transfusion
Isoantibodies
Erythrocyte Transfusion
Incidence
Immunoglobulins
Anemia
Pregnant Women
Antibodies

ASJC Scopus subject areas

  • Hematology

Cite this

Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kpb . / Bleile, Michelle J.; Rijhsinghani, Asha; Dwyre, Denis M; Raife, Thomas J.

In: Transfusion and Apheresis Science, Vol. 43, No. 3, 12.2010, p. 281-283.

Research output: Contribution to journalArticle

@article{129d238dc11b482295a4ddb0b6d22d94,
title = "Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kpb",
abstract = "Background: The incidence of hemolytic disease of the fetus and newborn (HDFN) has decreased since the introduction of Rh immunoglobulin prophylaxis in Rh(D)-negative pregnant women. Thus, the relative incidence of rare alloantibody-related HDFN has increased. The lack of available maternally matched red blood cells for transfusion in these cases may create management difficulties. Case: We report a case of anti-Kpb HDFN. Severe fetal anemia required intrauterine transfusion. Difficulty in obtaining Kpb-negative blood necessitated using the mother's donated RBCs. Conclusion: Severe HDFN with rare antibodies can be managed successfully using maternal blood.",
author = "Bleile, {Michelle J.} and Asha Rijhsinghani and Dwyre, {Denis M} and Raife, {Thomas J.}",
year = "2010",
month = "12",
doi = "10.1016/j.transci.2010.09.010",
language = "English (US)",
volume = "43",
pages = "281--283",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kpb

AU - Bleile, Michelle J.

AU - Rijhsinghani, Asha

AU - Dwyre, Denis M

AU - Raife, Thomas J.

PY - 2010/12

Y1 - 2010/12

N2 - Background: The incidence of hemolytic disease of the fetus and newborn (HDFN) has decreased since the introduction of Rh immunoglobulin prophylaxis in Rh(D)-negative pregnant women. Thus, the relative incidence of rare alloantibody-related HDFN has increased. The lack of available maternally matched red blood cells for transfusion in these cases may create management difficulties. Case: We report a case of anti-Kpb HDFN. Severe fetal anemia required intrauterine transfusion. Difficulty in obtaining Kpb-negative blood necessitated using the mother's donated RBCs. Conclusion: Severe HDFN with rare antibodies can be managed successfully using maternal blood.

AB - Background: The incidence of hemolytic disease of the fetus and newborn (HDFN) has decreased since the introduction of Rh immunoglobulin prophylaxis in Rh(D)-negative pregnant women. Thus, the relative incidence of rare alloantibody-related HDFN has increased. The lack of available maternally matched red blood cells for transfusion in these cases may create management difficulties. Case: We report a case of anti-Kpb HDFN. Severe fetal anemia required intrauterine transfusion. Difficulty in obtaining Kpb-negative blood necessitated using the mother's donated RBCs. Conclusion: Severe HDFN with rare antibodies can be managed successfully using maternal blood.

UR - http://www.scopus.com/inward/record.url?scp=78649485318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649485318&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2010.09.010

DO - 10.1016/j.transci.2010.09.010

M3 - Article

C2 - 20951648

AN - SCOPUS:78649485318

VL - 43

SP - 281

EP - 283

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 3

ER -